Drugs and driving;Arzneimittel und fahrtüchtigkeit

Therapeutische Umschau

Volumn 60, Issue 6, 2003, Pages 347-354

  Morike K ^a   Gleiter, Ch H ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ANTIDIABETIC AGENT; ANTIHISTAMINIC AGENT; BENZODIAZEPINE DERIVATIVE; CETIRIZINE; FEXOFENADINE; LORATADINE; TRICYCLIC ANTIDEPRESSANT AGENT;

ALERTNESS; DRIVING ABILITY; DRUG CONTRAINDICATION; DRUG EFFECT; HUMAN; HYPOGLYCEMIA; PRESCRIPTION; PSYCHOMOTOR ACTIVITY; REVIEW; RISK ASSESSMENT; SEDATION; SOMNOLENCE;

EID: 0037937323     PISSN: 00405930     EISSN: None     Source Type: Journal    
DOI: 10.1024/0040-5930.60.6.347     Document Type: Review

References (42)

1. Frier BM. Hypoglycemia and driving performance. Diabetes Care 2000; 23: 148-50.
2. Soyka M, Kagerer S, Gartenmaier A. Verkehrssicherheit bei psychischen Störungen. Übersicht und Kommentar zu den aktuellen Begutachtungsleitlinien zur Kraftfahreignung. Nervenheilkunde 2001; 20: 511-8.
3. O'Neill D. Benzodiazepines and driver safety. Lancet 1998; 352: 1324-30.
4. Lyznicki JL, Doege TC, Davis RM, Williams MA, for the Council on Scientific Affairs, American Medical Association. Sleepiness, driving, and motor vehicle crashes. JAMA 1998; 279: 1908-13.
5. Kupfer DJ, Reynolds CF. Management of insomnia. N Engl J Med 1997; 336: 341-6.
6. Sjögren H, Björnstig U, Eriksson A, Öhman U, Solarz A. Drug and alcohol use among injured motor vehicle drivers in Sweden: Prevalence, driver, crash, and injury characteristics. Alcohol Clin Exp Res 1997; 21: 968-73.
7. Ray WA, Fought RL, Decker MD. Psychoactive drugs and the risk of injurious motor vehicle crashes in elderly drivers. Am J Epidemiol 1992; 136: 873-83.
8. Barbone F, McMahon AD, Davey PG, et al. Association of road-traffic accidents with benzodiazepine use. Lancet 1998; 352: 1331-36.
9. Neutel CI. Risk of traffic accident injury after a prescription for a benzodiazepine. Ann Epidemiol 1995; 5: 239-44.
10. Hemmelgarn B, Suissa S, Huang A, Boivin J-F, Pinard G. Benzodiazepine use and the risk of motor vehicle crash in the elderly. JAMA 1997; 278: 27-31.
11. Ray WA. Safety and mobility of the older driver: a research challenge. JAMA 1997; 278: 66-7.
12. Schwab M, Röder F, Ammon S, Thon K-P, Mörike K. Increased number of hip fractures. Lancet 1999; 353: 2160.
13. Amoroso PJ, Reynolds KL, Bell NS, et al. Benzodiazepine use and crash risk in older patients. JAMA 1998; 279: 113-5 (correspondence).
14. Longo M, Hunter CE, Lokan RJ, White JM, White MA. The prevalence of alcohol, cannabinoids, benzodiazepines and stimulants amongst injured drivers and their role in driver culpability. Part II: the relationship between drug prevalence and drug concentration, and driver culpability. Accid Anal Prev 2000; 32: 623-32.
15. Logan BK, Couper FJ. Zolpidem and driving impairment. J Forensic Sci 2001; 46: 105-10.
16. Leveille SG, Buchner DM, Koepsell TD, McCloskey LW, Wolf ME, Wagner EH. Psychoactive medications and injurious motor vehicle collisions involving older drivers. Epidemiology 1994; 5: 591-8.
17. Hu PS, Trumble DA, Foley DJ, Eberhard JW, Wallace RB. Crash risk of older drivers: A panel data analysis. Accid Anal Prev 1998; 30: 569-81.
18. Edwards JG. Depression, antidepressants, and accidents. BMJ 1995; 311: 887-8.
19. O'Hanlon JF, Robbe HW, Vermeeren A, van Leeuwen C, Danjou PE. Venlafaxine's effects on healthy volunteers' driving, psychomotor, and vigilance performance during 15-day fixed and incremental dosing regimens. J Clin Psychopharmacol 1998; 18: 212-21.
20. Cox DJ, Merkel RL, Kovatchev B, Seward R. Effect of stimulant medication on driving performance of young adults with attention-deficit hyperactivity disorder. A preliminary double-blind placebo controlled trial. J Nerv Ment Dis 2000; 188: 230-4.
21. Hennessy S, Strom BL. Nonsedating antihistamines should be preferred over sedating antihistamines in patients who drive. Ann Intern Med 2000; 132: 405-7.
22. Philpot EE. Safety of second generation antihistamines. Allergy Asthma Proc 2000; 21: 15-20.
23. O'Hanlon JF, Ramaekers JG. Antihistamine effects on actual driving performance in a standard test: s summary of Dutch experience, 1989-1994. Allergy 1995; 50: 234-42.
24. Mann RD, Pearce GL, Dunn N, Shakir S. Sedation with «non-sedating» antihistamines: four prescription-event monitoring studies in general practice. BMJ 2000; 320: 1184-87.
25. Weiler JM, Bloomfield JR, Woodworth GG, et al. Effects of fexofenadine, diphenhydramine, and alcohol on driving performance. A randomized, placebo-controlled trial in the Iowa Driving Simulator. Ann Intern Med 2000; 132: 354-63.
26. De Waard D, Brookhuis KA, Lee TH, et al. Drug effects on driving performance. Ann Intern Med 2000; 133: 656-8 (correspondence).
27. Logan BK, Case GA, Gordon AM. Carisoprodol, meprobamate, and driving impairment. J Forensic Sci 2000; 45: 619-23.
28. Krauss GL, Krumholz A, Carter RC, Li G, Kaplan P. Risk factors for seizure-related motor vehicle crashes in patients with epilepsy. Neurology 1999; 52: 1324-9.
29. Feely M. Drug treatment of epilepsy. BMJ 1999; 318: 106-9.
30. Frucht S, Rogers JD, Greene PE, Gordon MF, Fahn S. Falling asleep at the wheel: Motor vehicle mishaps in persons taking pramipexole and ropinirole. Neurology 1999; 52: 1908-10.
31. Strumpf M, Köhler A, Zenz M, Willweber-Strumpf A, Dertwinkel R, Donner B. Opioide und Fahrtüchtigkeit. Schmerz 1997; 11: 233-40.
32. Vainio A, Ollila J, Matikainen E, Rosenberg P, Kalso E. Driving ability in cancer patients receiving long-term morphine analgesia. Lancet 1995; 346: 667-70.
33. Hanks GW. Morphine sans Morpheus. Lancet 1995; 346: 652-3.
34. Meijler WJ. Driving ban for patients on chronic opioid therapy unfounded. Ned Tijdschr Geneesk 2000; 144: 1644-5.
35. Smith AM. Patients taking stable doses of morphine may drive. BMJ 1996; 312: 56-7.
36. Sabatowski R, Berghaus G, Strumpf M, Radbruch L. Opioide und Fahrtüchtigkeit - Ein unlösbares Problem? Dtsch Med Wochenschr 2003; 128: 337-41.
37. Foley DJ, Wallace RB, Eberhard J. Risk factors for motor vehicle crashes among older drivers in a rural community. J Am Geriatr Soc 1995; 43: 776-1.
38. McGwin G, Sims RV, Pulley L, Roseman JM. Relations among chronic medical conditions, medications, and automobile crashes in the elderly: A population-based case-control study. Am J Epidemiol 2000; 152: 424-31.
39. McGwin G, Sims RV, Pulley L, Roseman JM. Diabetes and automobile crashes in the elderly. A population-based case-control study. Diabetes Care 1999; 22: 220-7.
40. Marrero D, Edelman S. Hypoglycemia and driving performance. Diabetes Care 2000; 23: 146-7.
41. Cox DJ, Gonder-Frederick LA, Kovatchev BP, Julian DM, Clarke WL. Progressive hypoglycemia's impact on driving simulation performance: occurrence, awareness, and correction. Diabetes Care 2000; 23: 163-70.
42. Ray WA, Thapa PB, Shorr RI. Medications and the older driver. Medications and the older driver. Clin Geriatr Med 1993; 9: 413-38.